Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor
To the Editor: Sexual assault nurse examiners
working for the San Francisco Department of Public Health at San Francisco
General Hospital have offered human immunodeficiency virus (HIV) postexposure
prophylaxis (PEP) to survivors of sexual assault since April 1998. Survivors
who choose to initiate PEP are given zidovudine (300 mg, twice daily) and
lamivudine (150 mg, twice daily) in a combination pill for 10 days. At a follow-up
visit 7 to 10 days later, an additional 18 days of the same PEP medications
are offered. However, characteristics of those who choose to initiate and
complete PEP have not been well described.
Myles JE, Hirozawa A, Katz MH, Kimmerling R, Bamberger JD. Postexposure Prophylaxis for HIV After Sexual Assault. JAMA. 2000;284(12):1516–1518. doi:10.1001/jama.284.12.1512
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: